AGO2 and glioblastoma: For instance, Zhang et al. (2019) found that circ-Foxo3 and miR-138-5p/miR-432-5p were enriched for AGO2 through an anti-AGO2 RIP assay, indicating that circ-Foxo3 downregulated NFAT5 by sponging miR-138-5p/miR-432-5p, inhibiting the progression of Glioblastoma.